title: Mechanism of partial agonism at the GluR2 AMPA receptor: Measurements of lobe orientation in solution.
abstract: The mechanism by which the binding of a neurotransmitter to a receptor leads to channel opening is a central issue in molecular neurobiology. The structure of the agonist binding domain of ionotropic glutamate receptors has led to an improved understanding of the changes in structure that accompany agonist binding and have provided important clues about the link between these structural changes and channel activation and desensitization. However, because the binding domain has exhibited different structures under different crystallization conditions, understanding the structure in the absence of crystal packing is of considerable importance. The orientation of the two lobes of the binding domain in the presence of a full agonist, an antagonist, and several partial agonists was measured using NMR spectroscopy by employing residual dipolar couplings. For some partial agonists, the solution conformation differs from that observed in the crystal. A model of channel activation based on the results is discussed.
authors.affiliation: Department of Molecular Medicine, Cornell University, Ithaca, New York 14853, USA.
authors.forename: Alexander S
authors.initials: AS
authors.lastname: Maltsev
authors.forename: Ahmed H
authors.initials: AH
authors.lastname: Ahmed
authors.forename: Michael K
authors.initials: MK
authors.lastname: Fenwick
authors.forename: David E
authors.initials: DE
authors.lastname: Jane
authors.forename: Robert E
authors.initials: RE
authors.lastname: Oswald
mesh_terms: D000409:Alanine / Q000031:analogs & derivatives / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D018360:Crystallography, X-Ray; D018698:Glutamic Acid / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D007608:Kainic Acid / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D008958:Models, Molecular; D019906:Nuclear Magnetic Resonance, Biomolecular; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D051381:Rats; D018091:Receptors, AMPA / Q000819:agonists* / Q000737:chemistry* / Q000378:metabolism; D012996:Solutions; D014498:Uracil / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology
chemical_list: D018091:Receptors, AMPA; D012996:Solutions; C002872:willardiine; D018698:Glutamic Acid; D014498:Uracil; D000409:Alanine; C104722:glutamate receptor ionotropic, AMPA 2; D007608:Kainic Acid
references.citation: J Biomol NMR. 2001 Oct;21(2):141-51
references.pmid: 11727977
references.citation: Proteins. 2009 May 15;75(3):628-37
references.pmid: 19003990
references.citation: J Neurosci. 1992 Feb;12(2):595-606
references.pmid: 1371315
references.citation: Pharmacol Rev. 1999 Mar;51(1):7-61
references.pmid: 10049997
references.citation: Nature. 2002 May 16;417(6886):245-53
references.pmid: 12015593
references.citation: Neuron. 2005 Jul 7;47(1):71-84
references.pmid: 15996549
references.citation: Phys Biol. 2005 Nov 09;2(4):S137-47
references.pmid: 16280619
references.citation: Nature. 2006 Mar 23;440(7083):456-62
references.pmid: 16554805
references.citation: J Am Chem Soc. 2003 Jul 30;125(30):9179-91
references.pmid: 15369375
references.citation: Structure. 2007 Oct;15(10):1203-14
references.pmid: 17937910
references.citation: Nat Struct Biol. 1997 Jun;4(6):443-9
references.pmid: 9187651
references.citation: J Am Chem Soc. 2001 Feb 21;123(7):1416-24
references.pmid: 11456715
references.citation: Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13431-6
references.pmid: 9391042
references.citation: J Neurosci. 2008 Jan 23;28(4):932-43
references.pmid: 18216201
references.citation: J Mol Biol. 2008 May 2;378(3):673-85
references.pmid: 18387631
references.citation: Neuron. 2000 Oct;28(1):165-81
references.pmid: 11086992
references.citation: Biochemistry. 2002 Aug 20;41(33):10472-81
references.pmid: 12173934
references.citation: J Neurosci. 2005 Apr 13;25(15):3752-62
references.pmid: 15829627
references.citation: Biochemistry. 2003 May 13;42(18):5201-13
references.pmid: 12731861
references.citation: Nat Struct Biol. 1997 Sep;4(9):732-8
references.pmid: 9303001
references.citation: Nature. 1998 Oct 29;395(6705):913-7
references.pmid: 9804426
references.citation: Biochemistry. 2005 Mar 8;44(9):3410-7
references.pmid: 15736951
references.citation: J Biol Chem. 2007 Apr 27;282(17):12773-84
references.pmid: 17337449
references.citation: J Biomol NMR. 1995 Nov;6(3):277-93
references.pmid: 8520220
references.citation: Biophys J. 2002 Feb;82(2):676-83
references.pmid: 11806910
references.citation: J Biomol NMR. 2000 Apr;16(4):329-37
references.pmid: 10826884
references.citation: Biomol NMR Assign. 2007 Dec;1(2):241-3
references.pmid: 19636875
references.citation: Nat Neurosci. 2003 Aug;6(8):803-10
references.pmid: 12872125
references.citation: Methods Enzymol. 2004;380:170-87
references.pmid: 15051337
references.citation: Biochemistry. 2007 Feb 6;46(5):1343-9
references.pmid: 17260963
references.citation: Biochemistry. 2008 Jan 8;47(1):398-404
references.pmid: 18081322
references.citation: J Med Chem. 1997 Oct 24;40(22):3645-50
references.pmid: 9357531
references.citation: EMBO J. 2003 Jun 16;22(12):2873-85
references.pmid: 12805203
references.citation: Mol Neurobiol. 1996 Feb;12(1):1-11
references.pmid: 8732537
references.citation: Annu Rev Neurosci. 1994;17:31-108
references.pmid: 8210177
references.citation: Science. 1998 Jun 5;280(5369):1596-9
references.pmid: 9616121
references.citation: J Mol Biol. 2000 Feb 4;295(5):1265-73
references.pmid: 10653702
references.citation: J Mol Graph Model. 2002 Dec;21(3):181-3
references.pmid: 12463636
references.citation: J Magn Reson. 2003 Jan;160(1):65-73
references.pmid: 12565051
references.citation: Proc Natl Acad Sci U S A. 2003 May 13;100(10):5736-41
references.pmid: 12730367
references.citation: J Am Chem Soc. 2002 Oct 9;124(40):12020-30
references.pmid: 12358549
references.citation: Adv Protein Chem. 2004;68:313-49
references.pmid: 15500865
references.citation: J Med Chem. 2005 Dec 1;48(24):7867-81
references.pmid: 16302825